National Bank Of Canada Bio N Tech Se Transaction History
National Bank Of Canada
- $90.1 Billion
- Q2 2025
A detailed history of National Bank Of Canada transactions in Bio N Tech Se stock. As of the latest transaction made, National Bank Of Canada holds 603 shares of BNTX stock, worth $66,933. This represents 0.0% of its overall portfolio holdings.
Number of Shares
603
Previous 603
-0.0%
Holding current value
$66,933
Previous $64,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding BNTX
# of Institutions
317Shares Held
40.9MCall Options Held
1.37MPut Options Held
1.52M-
Baillie Gifford & CO8.04MShares$892 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.23MShares$470 Million1.88% of portfolio
-
Primecap Management CO Pasadena, CA4MShares$444 Million0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.6MShares$399 Million0.24% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$210 Million0.0% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $26.9B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...